STIM1-dependent peripheral coupling governs the contractility of vascular smooth muscle cells

  1. Vivek Krishnan
  2. Sher Ali
  3. Albert L Gonzales
  4. Pratish Thakore
  5. Caoimhin S Griffin
  6. Evan Yamasaki
  7. Michael G Alvarado
  8. Martin T Johnson
  9. Mohamed Trebak
  10. Scott Earley  Is a corresponding author
  1. University of Nevada Reno, United States
  2. University of Nevada, Reno, United States
  3. Penn State University, United States
  4. University of Pittsburgh, United States

Abstract

Peripheral coupling between the sarcoplasmic reticulum (SR) and plasma membrane (PM) forms signaling complexes that regulate the membrane potential and contractility of vascular smooth muscle cells (VSMCs). The mechanisms responsible for these membrane interactions are poorly understood. In many cells, STIM1 (stromal-interaction molecule 1), a single transmembrane-domain protein that resides in the endoplasmic reticulum (ER), transiently moves to ER-PM junctions in response to depletion of ER Ca2+ stores and initiates store-operated Ca2+ entry (SOCE). Fully differentiated VSMCs express STIM1 but exhibit only marginal SOCE activity. We hypothesized that STIM1 is constitutively active in contractile VSMCs and maintains peripheral coupling. In support of this concept, we found that the number and size of SR-PM interacting sites were decreased, and SR-dependent Ca2+ signaling processes were disrupted in freshly isolated cerebral artery SMCs from tamoxifen-inducible, SMC-specific STIM1-knockout (Stim1-smKO) mice. VSMCs from Stim1-smKO mice also exhibited a reduction in nanoscale colocalization between Ca2+-release sites on the SR and Ca2+-activated ion channels on the PM, accompanied by diminished channel activity. Stim1-smKO mice were hypotensive, and resistance arteries isolated from them displayed blunted contractility. These data suggest that STIM1 - independent of SR Ca2+ store depletion - is critically important for stable peripheral coupling in contractile VSMCs.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. All source data files and blots images have been provided.

Article and author information

Author details

  1. Vivek Krishnan

    Department of Pharmacology, University of Nevada Reno, Reno, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5064-4910
  2. Sher Ali

    Department of Pharmacology, University of Nevada Reno, Reno, United States
    Competing interests
    No competing interests declared.
  3. Albert L Gonzales

    Department of Physiology and Cell Biology, University of Nevada Reno, Reno, United States
    Competing interests
    No competing interests declared.
  4. Pratish Thakore

    Department of Pharmacology, University of Nevada, Reno, Reno, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2086-5453
  5. Caoimhin S Griffin

    Department of Pharmacology, University of Nevada Reno, Reno, United States
    Competing interests
    No competing interests declared.
  6. Evan Yamasaki

    Department of Pharmacology, University of Nevada Reno, Reno, United States
    Competing interests
    No competing interests declared.
  7. Michael G Alvarado

    Department of Pharmacology, University of Nevada Reno, Reno, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3489-9021
  8. Martin T Johnson

    Department of Cellular and Molecular Physiology, Penn State University, Hershey, United States
    Competing interests
    No competing interests declared.
  9. Mohamed Trebak

    Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, United States
    Competing interests
    Mohamed Trebak, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6759-864X
  10. Scott Earley

    Department of Pharmacology, University of Nevada Reno, Reno, United States
    For correspondence
    searley@med.unr.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9560-2941

Funding

National Heart, Lung, and Blood Institute (R35HL155008)

  • Scott Earley

National Heart, Lung, and Blood Institute (R35HL150778)

  • Mohamed Trebak

National Heart, Lung, and Blood Institute (K01HL138215)

  • Albert L Gonzales

National Heart, Lung, and Blood Institute (R01HL137852)

  • Scott Earley

National Heart, Lung, and Blood Institute (R01HL091905)

  • Scott Earley

National Heart, Lung, and Blood Institute (R01HL139585)

  • Scott Earley

National Heart, Lung, and Blood Institute (R01HL122770)

  • Scott Earley

National Heart, Lung, and Blood Institute (R01HL146054)

  • Scott Earley

National Institute of Neurological Disorders and Stroke (RF1NS110044)

  • Scott Earley

National Institute of Neurological Disorders and Stroke (R61NS115132)

  • Scott Earley

National Institute of General Medical Sciences (P20GM130459)

  • Scott Earley

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Murali Prakriya, Northwestern University, United States

Ethics

Animal experimentation: All animal studies were performed in strict accordance with the guidelines of the Institutional Animal Care and Use Committee (IACUC) of the University of Nevada, Reno, and in accordance with the approved protocol 20-06-2020. All surgery was performed under isoflurane anesthesia, and every effort was made to minimize suffering, including preoperative analgesia provided by subcutaneous injection of 50 µg/kg buprenorphine.

Version history

  1. Received: May 12, 2021
  2. Preprint posted: May 26, 2021 (view preprint)
  3. Accepted: February 10, 2022
  4. Accepted Manuscript published: February 11, 2022 (version 1)
  5. Version of Record published: March 24, 2022 (version 2)

Copyright

© 2022, Krishnan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,495
    views
  • 275
    downloads
  • 19
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Vivek Krishnan
  2. Sher Ali
  3. Albert L Gonzales
  4. Pratish Thakore
  5. Caoimhin S Griffin
  6. Evan Yamasaki
  7. Michael G Alvarado
  8. Martin T Johnson
  9. Mohamed Trebak
  10. Scott Earley
(2022)
STIM1-dependent peripheral coupling governs the contractility of vascular smooth muscle cells
eLife 11:e70278.
https://doi.org/10.7554/eLife.70278

Share this article

https://doi.org/10.7554/eLife.70278

Further reading

    1. Structural Biology and Molecular Biophysics
    Colin H Peters, Rohit K Singh ... John R Bankston
    Research Article

    Lymphoid restricted membrane protein (LRMP) is a specific regulator of the hyperpolarization-activated cyclic nucleotide-sensitive isoform 4 (HCN4) channel. LRMP prevents cAMP-dependent potentiation of HCN4, but the interaction domains, mechanisms of action, and basis for isoform-specificity remain unknown. Here, we identify the domains of LRMP essential for this regulation, show that LRMP acts by disrupting the intramolecular signal transduction between cyclic nucleotide binding and gating, and demonstrate that multiple unique regions in HCN4 are required for LRMP isoform-specificity. Using patch clamp electrophysiology and Förster resonance energy transfer (FRET), we identified the initial 227 residues of LRMP and the N-terminus of HCN4 as necessary for LRMP to associate with HCN4. We found that the HCN4 N-terminus and HCN4-specific residues in the C-linker are necessary for regulation of HCN4 by LRMP. Finally, we demonstrated that LRMP-regulation can be conferred to HCN2 by addition of the HCN4 N-terminus along with mutation of five residues in the S5 region and C-linker to the cognate HCN4 residues. Taken together, these results suggest that LRMP inhibits HCN4 through an isoform-specific interaction involving the N-terminals of both proteins that prevents the transduction of cAMP binding into a change in channel gating, most likely via an HCN4-specific orientation of the N-terminus, C-linker, and S4-S5 linker.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Isabelle Petit-Hartlein, Annelise Vermot ... Franck Fieschi
    Research Article

    NADPH oxidases (NOX) are transmembrane proteins, widely spread in eukaryotes and prokaryotes, that produce reactive oxygen species (ROS). Eukaryotes use the ROS products for innate immune defense and signaling in critical (patho)physiological processes. Despite the recent structures of human NOX isoforms, the activation of electron transfer remains incompletely understood. SpNOX, a homolog from Streptococcus pneumoniae, can serves as a robust model for exploring electron transfers in the NOX family thanks to its constitutive activity. Crystal structures of SpNOX full-length and dehydrogenase (DH) domain constructs are revealed here. The isolated DH domain acts as a flavin reductase, and both constructs use either NADPH or NADH as substrate. Our findings suggest that hydride transfer from NAD(P)H to FAD is the rate-limiting step in electron transfer. We identify significance of F397 in nicotinamide access to flavin isoalloxazine and confirm flavin binding contributions from both DH and Transmembrane (TM) domains. Comparison with related enzymes suggests that distal access to heme may influence the final electron acceptor, while the relative position of DH and TM does not necessarily correlate with activity, contrary to previous suggestions. It rather suggests requirement of an internal rearrangement, within the DH domain, to switch from a resting to an active state. Thus, SpNOX appears to be a good model of active NOX2, which allows us to propose an explanation for NOX2’s requirement for activation.